Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 28 04:00PM ET
59.98
Dollar change
-1.02
Percentage change
-1.67
%
IndexS&P 500 P/E22.68 EPS (ttm)2.64 Insider Own1.20% Shs Outstand224.29M Perf Week-0.58%
Market Cap13.47B Forward P/E11.20 EPS next Y5.36 Insider Trans-0.65% Shs Float221.84M Perf Month-0.81%
Income597.60M PEG1.01 EPS next Q0.89 Inst Own98.84% Short Float3.92% Perf Quarter13.45%
Sales3.70B P/S3.64 EPS this Y25.46% Inst Trans0.60% Short Ratio4.63 Perf Half Y-7.48%
Book/sh23.14 P/B2.59 EPS next Y21.07% ROA9.41% Short Interest8.70M Perf Year-21.71%
Cash/sh16.28 P/C3.68 EPS next 5Y22.50% ROE12.50% 52W Range50.27 - 78.02 Perf YTD-4.48%
Dividend Est.- P/FCF29.02 EPS past 5Y38.99% ROI11.42% 52W High-23.12% Beta0.67
Dividend TTM- Quick Ratio3.69 Sales past 5Y14.55% Gross Margin91.47% 52W Low19.32% ATR (14)1.60
Dividend Ex-Date- Current Ratio3.75 EPS Y/Y TTM73.98% Oper. Margin17.64% RSI (14)50.80 Volatility2.54% 2.72%
Employees2524 Debt/Eq0.01 Sales Y/Y TTM8.87% Profit Margin16.17% Recom1.96 Target Price75.61
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q602.37% Payout0.00% Rel Volume0.60 Prev Close61.00
Sales Surprise1.06% EPS Surprise-7.85% Sales Q/Q9.35% EarningsFeb 13 BMO Avg Volume1.88M Price59.98
SMA201.68% SMA50-1.97% SMA200-0.90% Trades Volume1,118,692 Change-1.67%
Date Action Analyst Rating Change Price Target Change
Feb-23-24Initiated Jefferies Buy $81
Feb-14-24Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-13-23Upgrade Leerink Partners Market Perform → Outperform $78
Dec-04-23Upgrade Guggenheim Neutral → Buy $86
Nov-21-23Downgrade Goldman Buy → Neutral $98 → $65
Jul-25-23Initiated Citigroup Buy $82
May-04-23Downgrade BofA Securities Buy → Neutral $84
Apr-10-23Downgrade RBC Capital Mkts Outperform → Sector Perform $81 → $79
Mar-24-23Upgrade SVB Securities Underperform → Market Perform $61
Jan-31-23Initiated Piper Sandler Overweight $100
Feb-28-24 01:10PM
Feb-27-24 04:08PM
Feb-21-24 04:50PM
Feb-15-24 08:00AM
Feb-14-24 09:32AM
01:15AM Loading…
01:15AM
12:12AM
Feb-13-24 05:43PM
11:37AM
09:30AM
08:26AM
08:25AM
07:38AM
07:35AM
07:34AM
07:00AM Loading…
07:00AM
Feb-09-24 11:03AM
09:15AM
Feb-07-24 08:55AM
Feb-06-24 04:30AM
Feb-05-24 06:54PM
04:46PM
Jan-31-24 07:33PM
Jan-30-24 11:07AM
Jan-26-24 09:12AM
Jan-24-24 08:39AM
Jan-23-24 08:00AM
Jan-18-24 04:00PM
Jan-08-24 08:30AM
Jan-06-24 11:02AM
07:19PM Loading…
Jan-02-24 07:19PM
Dec-20-23 01:50PM
Dec-19-23 11:41AM
Dec-15-23 02:30PM
Dec-12-23 12:46PM
08:00AM
Dec-10-23 05:00PM
Dec-05-23 10:32AM
Nov-30-23 11:31AM
Nov-16-23 12:17PM
Nov-13-23 09:50PM
Nov-12-23 08:18AM
Nov-09-23 10:01PM
Nov-02-23 09:00AM
Nov-01-23 12:32PM
Oct-31-23 09:52PM
12:14PM
09:36AM
09:30AM
08:43AM
08:15AM
07:09AM
07:00AM
Oct-30-23 11:37AM
Oct-27-23 11:36AM
08:00AM
Oct-25-23 10:02AM
Oct-20-23 12:04PM
Oct-18-23 08:00AM
Oct-16-23 08:00AM
07:30AM
Oct-13-23 12:44PM
10:30AM
08:00AM
Oct-12-23 11:29AM
09:00AM
Oct-11-23 10:30AM
09:15AM
08:15AM
Oct-10-23 04:45PM
08:00AM
Sep-29-23 01:43PM
Sep-26-23 12:33PM
Sep-21-23 07:11PM
Sep-20-23 12:12PM
Sep-18-23 04:07PM
11:36AM
09:59AM
Aug-31-23 11:31AM
Aug-22-23 08:00AM
Aug-08-23 06:20AM
Aug-04-23 04:33PM
Aug-02-23 07:32PM
Aug-01-23 05:00PM
10:05AM
09:30AM
08:25AM
08:21AM
07:17AM
07:00AM
Jul-31-23 04:01PM
09:58AM
Jul-27-23 10:20AM
Jul-26-23 10:02AM
Jul-25-23 10:06AM
10:01AM
Jul-24-23 07:00AM
Jul-12-23 12:37PM
12:22PM
10:52AM
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stein Steven HEVP & Chief Medical OfficerJan 03Sale65.517,365482,48190,218Jan 05 12:27 PM
Iyengar Vijay KEVP, GMAPPSJan 02Sale65.0065742,70543,412Jan 04 01:05 PM
Tray ThomasPrincipal Accounting OfficerDec 13Sale62.371,06766,54923,436Dec 14 02:11 PM
Tray ThomasPrincipal Accounting OfficerDec 12Sale57.3621012,04624,503Dec 14 02:11 PM
SWAIN PAULA JEVP, Human ResourcesSep 01Sale65.138,449550,28377,530Sep 06 04:00 PM
Stein Steven HEVP & Chief Medical OfficerAug 01Sale63.2821,5111,361,21697,583Aug 03 04:00 PM
BAKER BROS. ADVISORS LPDirectorMar 13Option Exercise22.7440,000909,60033,442,926Mar 15 04:03 PM